XML 64 R26.htm IDEA: XBRL DOCUMENT v3.20.1
Stock based compensation (Tables)
3 Months Ended
Mar. 31, 2020
Stock based compensation  
Compensation cost recognized for all stock-based compensation awards

Total compensation cost recognized for all stock-based compensation awards in the condensed consolidated statements of operations and comprehensive loss is as follows:

​

​

​

​

​

​

​

​

​

​

Three Months Ended

​

​

​

March 31, 

 

​

    

2020

    

2019

 

​

​

(in thousands)

​

Research and development

​

$

1,685

​

$

1,416

​

General and administrative

​

 

2,355

​

 

2,102

​

Total stock-based compensation expense

​

$

4,040

​

$

3,518

​

Summary of stock-based compensation expense by classification

​

​

​

​

​

​

​

​

​

​

​

Three Months Ended

​

​

​

March 31, 

​

​

    

2020

    

2019

​

​

​

(in thousands)

​

Stock options

​

$

3,208

​

$

2,776

​

Restricted stock awards and units

​

​

741

​

​

683

​

Employee stock purchase plan awards

​

 

91

​

 

59

​

Total stock-based compensation expense

​

$

4,040

​

$

3,518

​

Summary of status and changes in unvested restricted stock

​

​

​

​

​

​

​

​

​

​

​

    

Weighted

​

​

​

​

​

Average

​

​

​

​

​

Grant Date

​

​

​

​

​

Fair Value

​

​

    

Units

    

Per Unit

​

Unvested restricted stock units as of December 31, 2019

 

455,404

​

$

12.16

​

Granted

 

429,103

​

$

13.05

​

Vested

 

(108,600)

​

$

9.10

​

Forfeited

 

(28,480)

​

$

10.50

​

Unvested restricted stock units as of March 31, 2020

 

747,427

​

$

13.18

​

Summary of status and changes in stock options

The following is a summary of stock option activity for the three months ended March 31, 2020:

​

​

​

​

​

​

​

​

​

​

​

​

​

​

​

    

Weighted

    

Remaining

    

Aggregate

​

​

​

​

​

Average

​

Contractual

​

Intrinsic

​

​

​

​

​

Exercise

​

Life

​

Value

​

​

    

Shares

    

Price

    

(in years)

    

(in thousands)

​

Outstanding at December 31, 2019

 

5,317,326

​

$

15.98

​

​

​

​

​

​

Granted

 

899,085

​

$

12.88

​

​

​

​

​

​

Exercised

 

(3,035)

​

$

11.30

​

​

​

​

​

​

Cancelled or forfeited

 

(148,221)

​

$

15.66

​

​

​

​

​

​

Outstanding at March 31, 2020

 

6,065,155

​

$

15.53

​

7.9

​

$

391

​

Exercisable at March 31, 2020

 

2,723,252

​

$

14.77

​

6.6

​

$

350

​

Vested and expected to vest at March 31, 2020

 

6,065,155

​

$

15.53

​

7.9

​

$

391

​

Assumptions

The fair value of each option issued to employees and directors was estimated at the date of grant using the Black-Scholes option pricing model with the following weighted-average assumptions:

​

​

​

​

​

​

​

​

​

​

Three Months Ended

​

​

​

March 31, 

​

​

​

2020

    

2019

​

Risk-free interest rate

 

1.4

%  

 

2.5

%  

 

Expected dividend yield

 

—

%

 

—

%

 

Expected term (in years)

 

6.0

​

 

6.0

​

 

Expected volatility

 

72.3

%  

 

75.0

%